Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The closing price of Gossamer Bio Inc (NASDAQ: GOSS) was $1.76 for the day, up 1.15% from the previous closing price of $1.74. In other words, the price has increased by $1.15 from its previous closing price. On the day, 3.07 million shares were traded. GOSS stock price reached its highest trading level at $1.7897 during the session, while it also had its lowest trading level at $1.665.
Ratios:
Our analysis of GOSS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.40 and its Current Ratio is at 4.40.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Scotiabank on July 14, 2025, initiated with a Sector Outperform rating and assigned the stock a target price of $11.
On June 25, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $9.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GOSS now has a Market Capitalization of 400190528 and an Enterprise Value of 390104864. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.95. Its current Enterprise Value per Revenue stands at 9.695 whereas that against EBITDA is -2.685.
Stock Price History:
The Beta on a monthly basis for GOSS is 1.94, which has changed by 1.2138364 over the last 52 weeks, in comparison to a change of 0.19554341 over the same period for the S&P500. Over the past 52 weeks, GOSS has reached a high of $2.23, while it has fallen to a 52-week low of $0.66. The 50-Day Moving Average of the stock is 17.08%, while the 200-Day Moving Average is calculated to be 56.46%.
Shares Statistics:
GOSS traded an average of 2.49M shares per day over the past three months and 3711990 shares per day over the past ten days. A total of 227.32M shares are outstanding, with a floating share count of 182.73M. Insiders hold about 19.64% of the company’s shares, while institutions hold 59.79% stake in the company. Shares short for GOSS as of 1752537600 were 18122038 with a Short Ratio of 7.27, compared to 1749772800 on 11076527. Therefore, it implies a Short% of Shares Outstanding of 18122038 and a Short% of Float of 8.49.
Earnings Estimates
A comprehensive evaluation of Gossamer Bio Inc (GOSS) is underway, with the input of 7.0 analysts contributing to its current rating.The consensus estimate for the next quarter is -$0.17, with high estimates of -$0.11 and low estimates of -$0.22.
Analysts are recommending an EPS of between -$0.67 and -$0.77 for the fiscal current year, implying an average EPS of -$0.71. EPS for the following year is -$0.47, with 8.0 analysts recommending between -$0.11 and -$0.89.
Revenue Estimates
A total of 9 analysts have provided revenue estimates for GOSS’s current fiscal year. The highest revenue estimate was $66.8M, while the lowest revenue estimate was $21.38M, resulting in an average revenue estimate of $36.41M. In the same quarter a year ago, actual revenue was $114.7M
